Andria Skinner

Title: Andria Skinner: Innovator in Antibody-Drug Conjugates

Introduction

Andria Skinner is a notable inventor based in Mohegan Lake, NY (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of 2 patents, her work has advanced the understanding and application of these innovative therapies.

Latest Patents

Andria's latest patents include "STABILIZED FORMULATIONS CONTAINING ANTI-ANGPTL3 ANTIBODIES" and "Methods of assessing antibody-drug conjugates." The latter patent provides methods for assessing the drug-to-antibody ratio (DAR) of ADC products, offering advantages over existing methods. These methods can be utilized in high-throughput applications and do not require dilution of ADC samples during assessment.

Career Highlights

Throughout her career, Andria has worked with prominent companies in the pharmaceutical industry, including Regeneron Pharmaceuticals, Inc. and Regeneran Pharmaceuticals, Inc. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in the field.

Collaborations

Andria has collaborated with talented professionals such as Natallia Kulyba and Dingjiang Liu. These partnerships have fostered innovation and have been instrumental in her research endeavors.

Conclusion

Andria Skinner's contributions to the field of biotechnology, particularly in antibody-drug conjugates, highlight her role as an influential inventor. Her patents and collaborations reflect her commitment to advancing medical science and improving therapeutic options.